Research graph
References from New insights into the pathogenesis of osteoporosis and the translational approach to personalized therapy. Local targets link to admitted publications; unresolved targets remain external evidence.
Assessment of fracture risk in women with eating disorders: the utility of dual-energy x-ray absorptiometry (DXA)-Clinical cohort study
10.1002/eat.23245 · 2020 · External reference
Assessment of sex differences in fracture risk among patients with Anorexia Nervosa: a population-based cohort study using the health improvement network
2017 · External reference
Endocrine consequences of anorexia nervosa
10.1016/s2213-8587(13)70180-3 · 2014 · External reference
Estrogen and the skeleton
10.1016/j.tem.2012.03.008 · 2012 · External reference
Alterations in growth hormone secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism
10.1210/jc.2003-030532 · 2003 · External reference
Cortisol decreases bone formation by inhibiting periosteal cell proliferation
10.1210/endo-114-2-477 · 1984 · External reference
Mechanisms of glucocorticoid action in bone
10.1111/j.1749-6632.2002.tb04204.x · 2002 · External reference
Peptide YY (PYY) levels and bone mineral density (BMD) in women with anorexia nervosa
10.1016/j.bone.2008.03.007 · 2008 · External reference
Peptide YY regulates bone remodeling in mice: a link between gut and skeletal biology
10.1371/journal.pone.0040038 · 2012 · External reference
PYY is a negative regulator of bone mass and strength
10.1016/j.bone.2019.07.011 · 2019 · External reference
Anorexia Nervosa and osteoporosis
10.1007/s00223-021-00826-3 · 2022 · External reference
Physiologic regulators of bone turnover in young women with anorexia nervosa
10.1067/mpd.2002.125003 · 2002 · External reference
Dehydroepiandrosterone sulfate, osteoprotegerin and its soluble ligand sRANKL and bone metabolism in girls with anorexia nervosa
10.5604/17322693.1009971 · 2012 · External reference
The oxytocin-bone axis
10.1111/jne.12120 · 2014 · External reference
Oxytocin and anorexia nervosa: a review of the emerging literature
10.1002/erv.2252 · 2013 · External reference
Low PTH levels in adolescents with Anorexia Nervosa
10.3389/fped.2020.00099 · 2020 · External reference
Effect of GLP-1 receptor agonists on bone mineral density, bone metabolism markers, and fracture risk in type 2 diabetes: a systematic review and meta-analysis
10.1007/s00592-025-02468-5 · 2025 · External reference
Glucagon-like Peptide-1 receptor agonists and diabetic osteopathy: another positive effect of incretines? A 12 months longitudinal study
10.1007/s00223-024-01240-1 · 2024 · External reference
Bone health after exercise alone, GLP-1 receptor agonist treatment, or combination treatment: a secondary analysis of a randomized clinical trial
10.1001/jamanetworkopen.2024.16775 · 2024 · External reference
Once-weekly semaglutide versus placebo in adults with increased fracture risk: a randomised, double-blinded, two-centre, phase 2 trial
10.1016/j.eclinm.2024.102624 · 2024 · External reference
Use of glucagon-like-peptide 1 receptor agonists and risk of fracture as compared to use of other anti-hyperglycemic drugs
10.1007/s00223-015-0037-y · 2015 · External reference
Bone fracture risk is not associated with the use of glucagon-like peptide-1 receptor agonists: a population-based cohort analysis
10.1007/s00223-015-9993-5 · 2015 · External reference
Use of glucagon-like peptide-1 receptor agonists and bone fractures: a meta-analysis of randomized clinical trials
10.1111/1753-0407.12102 · 2014 · External reference
Association of Glucagon-like peptide-1 receptor agonists use with fracture risk in type 2 diabetes: a meta-analysis of randomized controlled trials
10.1016/j.bone.2024.117338 · 2025 · External reference
Glucagon-like peptide-1 receptor agonists and fracture risk: a network meta-analysis of randomized clinical trials
10.1007/s00198-018-4649-8 · 2018 · External reference
Effects of anti-diabetic drugs on fracture risk: a systematic review and network meta-analysis
10.3389/fendo.2021.735824 · 2021 · External reference
Risk of bone fractures associated with glucagon-like peptide-1 receptor agonists’ treatment: a meta-analysis of randomized controlled trials
10.1007/s12020-014-0361-4 · 2015 · External reference
10.1016/j.yexcr.2017.09.018
10.1016/j.yexcr.2017.09.018 · 2017 · External reference
Semaglutide promotes the proliferation and osteogenic differentiation of bone-derived mesenchymal stem cells through activation of the Wnt/LRP5/β-catenin signaling pathway
10.3389/fphar.2025.1539411 · 2025 · External reference
The crucial role of beta-catenin in the osteoprotective effect of semaglutide in an ovariectomized rat model of osteoporosis
10.1007/s00210-024-03378-z · 2025 · External reference
Liraglutide, a glucagon-like peptide-1 receptor agonist, inhibits bone loss in an animal model of osteoporosis with or without diabetes
2024 · External reference
Liraglutide, a glucagon-like peptide-1 receptor agonist, suppresses osteoclastogenesis through the inhibition of NF-κB and MAPK pathways via GLP-1R
10.1016/j.biopha.2020.110523 · 2020 · External reference
Glucagon-like peptide-1 receptor agonist Liraglutide has anabolic bone effects in ovariectomized rats without diabetes
10.1371/journal.pone.0132744 · 2015 · External reference
Activation of GLP-1 receptor promotes bone marrow stromal cell osteogenic differentiation through β-Catenin
10.1016/j.stemcr.2016.02.002 · 2016 · External reference
Does diet-induced weight loss lead to bone loss in overweight or Obese adults? A systematic review and meta-analysis of clinical trials
10.1002/jbmr.2564 · 2015 · External reference
Effect of exercise modality during weight loss on bone health in older adults with obesity and cardiovascular disease or metabolic syndrome: a randomized controlled trial
10.1002/jbmr.3555 · 2018 · External reference
Reduced bone mineral density is not associated with significantly reduced bone quality in men and women practicing long-term calorie restriction with adequate nutrition
10.1111/j.1474-9726.2010.00643.x · 2011 · External reference
Relationships between serum leptin and bone markers during stable weight, weight reduction and weight regain in male and female judoists
10.1530/eje.1.02103 · 2006 · External reference
Areal and volumetric bone mineral density and geometry at two levels of protein intake during caloric restriction: a randomized, controlled trial
10.1002/jbmr.318 · 2011 · External reference
Effect of oral and transdermal oestrogen therapy on bone mineral density in functional hypothalamic amenorrhoea: a systematic review and meta-analysis
10.1136/bmjsem-2021-001112 · 2021 · External reference
Severity level and duration of energy deficit in mice affect bone phenotype and bone marrow stromal cell differentiation capacity
10.3389/fendo.2022.880503 · 2022 · External reference
Calorie restriction induces mandible bone loss by regulating mitochondrial function
10.1016/j.bone.2024.117326 · 2025 · External reference
Calorie restriction in mice impairs cortical but not trabecular peak bone mass by suppressing bone remodeling
10.1093/jbmr/zjae104 · 2024 · External reference
Relationship between skipping breakfast and bone mineral density in young Japanese women
2013 · External reference
Skipping breakfast and less exercise are risk factors for bone loss in young Japanese adults: a 3-year follow-up study
10.1007/s00774-013-0510-5 · 2014 · External reference
Alternate day fasting improves physiological and molecular markers of aging in healthy, non-obese humans
10.1016/j.cmet.2019.07.016 · 2019 · External reference
Effect of alternate day fasting on markers of bone metabolism: an exploratory analysis of a 6-month randomized controlled trial
10.3233/nha-170031 · 2017 · External reference
Effect of intermittent fasting on glucose homeostasis and bone remodeling in glucocorticoid-induced osteoporosis rat model
10.11005/jbm.2021.28.4.307 · 2021 · External reference
Intermittent fasting alleviates obesity-associated impairments in bone fracture healing: exploring the role of gut microbiome
2025 · External reference
Effects of time-restricted eating on weight loss and other metabolic parameters in women and men with overweight and obesity: the TREAT randomized clinical trial
10.1001/jamainternmed.2020.4153 · 2020 · External reference
Time-restricted eating in adults with metabolic syndrome: a randomized controlled trial
10.7326/m24-0859 · 2024 · External reference
Short-term time-restricted feeding is safe and feasible in Non-obese healthy midlife and older adults
10.1007/s11357-020-00156-6 · 2020 · External reference
Changes in menopausal risk factors in early postmenopausal osteopenic women after 13 months of high-intensity exercise: the randomized controlled ACTLIFE-RCT
10.2147/cia.s283177 · 2021 · External reference
A comparison of bone-targeted exercise with and without antiresorptive bone medication to reduce indices of fracture risk in postmenopausal women with low bone mass: the MEDEX-OP randomized controlled trial
10.1002/jbmr.4334 · 2021 · External reference
A comparison of bone-targeted exercise strategies to reduce fracture risk in middle-aged and older men with osteopenia and osteoporosis: LIFTMOR-M semi-randomized controlled trial
10.1002/jbmr.4008 · 2020 · External reference
Effects of supervised high-intensity resistance and impact training or machine-based isometric training on regional bone geometry and strength in middle-aged and older men with low bone mass: the LIFTMOR-M semi-randomised controlled trial
10.1016/j.bone.2020.115362 · 2020 · External reference
Effects of high-intensity resistance training on osteopenia and sarcopenia parameters in older men with Osteosarcopenia-One-Year results of the randomized controlled franconian osteopenia and sarcopenia trial (FrOST)
10.1002/jbmr.4027 · 2020 · External reference
Improved bone structure and strength after long-term mechanical loading is greatest if loading is separated into short bouts
10.1359/jbmr.2002.17.8.1545 · 2002 · External reference
Osteocyte: the unrecognized side of bone tissue
10.1007/s00198-010-1194-5 · 2010 · External reference
Senescent and apoptotic osteocytes and aging: exercise to the rescue?
10.1016/j.bone.2019.02.006 · 2019 · External reference
Tai Chi for risk of Falls. A meta-analysis
10.1111/jgs.15008 · 2017 · External reference
A 12-week iyengar yoga program improved balance and mobility in older community-dwelling people: a pilot randomized controlled trial
10.1093/gerona/glt087 · 2013 · External reference
The bone anabolic effects of irisin are through preferential stimulation of aerobic glycolysis
10.1016/j.bone.2018.05.013 · 2018 · External reference
Irisin prevents disuse-induced osteocyte apoptosis
10.1002/jbmr.3944 · 2020 · External reference
Effects of irisin on osteoblast apoptosis and osteoporosis in postmenopausal osteoporosis rats through upregulating Nrf2 and inhibiting NLRP3 inflammasome
2020 · External reference
Cumulative effects of strontium ranelate and impact exercise on bone mass in ovariectomized rats
10.3390/ijms22063040 · 2021 · External reference
Regular exercise limits alcohol effects on trabecular, cortical thickness and porosity, and osteocyte apoptosis in the rat
10.1016/j.jbspin.2012.12.005 · 2013 · External reference
Low magnitude vibration alleviates age-related bone loss by inhibiting cell senescence of osteogenic cells in naturally senescent rats
10.18632/aging.202907 · 2021 · External reference
The roles of exercise in bone remodeling and in prevention and treatment of osteoporosis
10.1016/j.pbiomolbio.2015.11.005 · 2016 · External reference
Interleukin-10 responses from acute exercise in healthy subjects: a systematic review
10.1002/jcp.27920 · 2019 · External reference
Moderate exercise training modulates cytokine profile and sleep in elderly people
10.1016/j.cyto.2012.07.028 · 2012 · External reference
Effect of exercise on inflammatory profile of older persons: systematic review and meta-analyses
10.1123/jpah.2016-0735 · 2018 · External reference
Influence of exercise training and age on CD14+ cell-surface expression of toll-like receptor 2 and 4
10.1016/j.bbi.2005.04.003 · 2005 · External reference
Influence of exercise on bone remodeling-related hormones and cytokines in ovariectomized rats: a model of postmenopausal osteoporosis
10.1371/journal.pone.0112845 · 2014 · External reference
Decreased activity of osteocyte autophagy with aging may contribute to the bone loss in senile population
10.1007/s00418-014-1194-1 · 2014 · External reference
Mechanically induced autophagy is associated with ATP metabolism and cellular viability in osteocytes in vitro
10.1016/j.redox.2017.10.021 · 2018 · External reference
Treadmill exercise ameliorates ethanol with lipopolysaccharide and carbon tetrachloride-mediated liver injury in mice
10.12965/jer.2244002.001 · 2022 · External reference
Coordinated time-dependent modulation of AMPK/Akt/mTOR signaling and autophagy controls osteogenic differentiation of human mesenchymal stem cells
10.1016/j.bone.2012.10.024 · 2013 · External reference
Irisin promotes osteogenic differentiation of bone marrow mesenchymal stem cells by activating autophagy via the Wnt//β-catenin signal pathway
10.1016/j.cyto.2020.155292 · 2020 · External reference
Autophagy attenuates the oxidative stress-induced apoptosis of Mc3T3-E1 osteoblasts
2017 · External reference
Suppression of autophagy by FIP200 deletion leads to osteopenia in mice through the inhibition of osteoblast terminal differentiation
10.1002/jbmr.1971 · 2013 · External reference
Inactivation of autophagy ameliorates glucocorticoid-induced and ovariectomy-induced bone loss
10.1136/annrheumdis-2015-207240 · 2016 · External reference
Increased gene expression of RUNX2 and SOX9 in mesenchymal circulating progenitors is associated with autophagy during physical activity
2019 · External reference
Tensile strain promotes osteogenic differentiation of bone marrow mesenchymal stem cells through upregulating lncRNA-MEG3
2021 · External reference
The mechanosensitive lncRNA Neat1 promotes osteoblast function through paraspeckle-dependent Smurf1 mRNA retention
10.1038/s41413-022-00191-3 · 2022 · External reference
microRNA-103a functions as a mechanosensitive microRNA to inhibit bone formation through targeting Runx2
10.1002/jbmr.2352 · 2015 · External reference
Trabecular bone microarchitecture improvement is associated with skeletal nerve increase following aerobic exercise training in middle-aged mice
2021 · External reference
Comprehensive analysis of circular RNA profiles in skeletal muscles of aging mice and after aerobic exercise intervention
10.18632/aging.102932 · 2020 · External reference
The epigenetic mechanism of mechanically induced osteogenic differentiation
10.1016/j.jbiomech.2010.07.033 · 2010 · External reference
Nrf2 epigenetic derepression induced by running exercise protects against osteoporosis
10.1038/s41413-020-00128-8 · 2021 · External reference
A six months exercise intervention influences the genome-wide DNA methylation pattern in human adipose tissue
10.1371/journal.pgen.1003572 · 2013 · External reference
Exercise effects on methylation of ASC gene
10.1055/s-0029-1246140 · 2010 · External reference
The impact of different modes of exercise training on bone mineral density in older postmenopausal women: a systematic review and meta-analysis research
10.1007/s00223-020-00671-w · 2020 · External reference
Effects of a 3-month weight-bearing and resistance exercise training on circulating osteogenic cells and bone formation markers in postmenopausal women with low bone mass
10.1007/s00198-019-04908-9 · 2019 · External reference
Effects of whole-body vibration and high impact exercises on the bone metabolism and functional mobility in postmenopausal women
10.1007/s00774-019-01072-2 · 2020 · External reference
In osteoporosis or osteopenia, exercise interventions improve BMD; effects vary by exercise type and BMD site
10.7326/j22-0014 · 2022 · External reference
Effect of aerobic or resistance exercise, or both, on bone mineral density and bone metabolism in Obese older adults while dieting: a randomized controlled trial
10.1002/jbmr.3905 · 2020 · External reference
Weighted vest use or resistance exercise to offset weight loss-associated bone loss in older adults: a randomized clinical trial
10.1001/jamanetworkopen.2025.16772 · 2025 · External reference
Bone marrow adipose tissue
10.3390/cells13090724 · 2024 · External reference
Bone marrow adipose tissue and skeletal health
10.1007/s11914-018-0451-y · 2018 · External reference
Bone marrow adipose tissue as a critical regulator of postmenopausal osteoporosis - a concise review
10.2147/cia.s466446 · 2024 · External reference
Bone marrow adiposity assessed by HRpQCT is related to fracture risk and bone mineral density in older Swedish women
10.1210/clinem/dgaf216 · 2025 · External reference
Osteoporosis and bone marrow adipose tissue
10.1007/s11914-022-00768-1 · 2023 · External reference
Clinical implications of bone marrow adiposity identified by phenome-wide association and Mendelian randomization in the UK Biobank
10.1038/s41467-025-63395-1 · 2025 · External reference
Clinical implications of bone marrow adiposity
10.1111/joim.12718 · 2018 · External reference
Adiponectin signalling in bone homeostasis, with age and in disease
10.1038/s41413-020-00122-0 · 2021 · External reference
Bone marrow adipocytes as novel regulators of metabolic homeostasis: clinical consequences of bone marrow adiposity
10.1007/s13679-024-00594-9 · 2025 · External reference
Participation of TNF-α in inhibitory effects of adipocytes on osteoblast differentiation
10.1002/jcp.25073 · 2016 · External reference
Primary human bone marrow adipocytes support TNF-α-induced osteoclast differentiation and function through RANKL expression
10.1016/j.cyto.2011.09.005 · 2011 · External reference
RANKL from bone marrow adipose lineage cells promotes osteoclast formation and bone loss
10.15252/embr.202152481 · 2021 · External reference
Interplay between bone marrow adiposity and bone resorption in RANKL-mediated modelled osteoporosis
10.1002/jcp.31434 · 2024 · External reference
Triglyceride metabolism in bone tissue is associated with osteoblast and osteoclast differentiation: a gene expression study
10.1007/s00774-013-0445-x · 2013 · External reference
Treatment with an inhibitor of fatty acid synthase attenuates bone loss in ovariectomized mice
10.1016/j.bone.2019.02.017 · 2019 · External reference
Saturated and unsaturated bone marrow lipids have distinct effects on bone density and fracture risk in older adults
10.1002/jbmr.4504 · 2022 · External reference
Body composition in anorexia nervosa: meta-analysis and meta-regression of cross-sectional and longitudinal studies
10.1002/eat.23158 · 2019 · External reference
Bone mineral density and estimated hip strength in men with anorexia nervosa, atypical anorexia nervosa and avoidant/restrictive food intake disorder
10.1111/cen.13960 · 2019 · External reference
Assessment of sex differences in bone deficits among adolescents with anorexia nervosa
10.1002/eat.22626 · 2017 · External reference
Bone density status in a large population of patients with anorexia nervosa
10.1016/j.bone.2019.115161 · 2020 · External reference
Fracture risk and areal bone mineral density in adolescent females with anorexia nervosa
10.1002/eat.22248 · 2014 · External reference
Fractures in women with eating disorders-Incidence, predictive factors, and the impact of disease remission: cohort study with background population controls
10.1002/eat.23223 · 2020 · External reference
Bone density, body composition, and psychopathology of anorexia nervosa spectrum disorders in DSM-IV vs DSM-5
10.1002/eat.22603 · 2017 · External reference
Anorexia nervosa and risk of fractures: a matched cohort study of 80,000 men and women
10.1016/j.amjmed.2025.09.027 · 2026 · External reference
The association between body mass index and osteoporosis, with consideration of sex differences: a systematic review and dose-response meta-analysis
10.1186/s12891-026-09675-3 · 2026 · External reference
The association between body mass index and osteoporosis in a Taiwanese population: a cross-sectional and longitudinal study
10.1038/s41598-024-59159-4 · 2024 · External reference
Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa
10.7326/0003-4819-133-10-200011210-00011 · 2000 · External reference
Hip structural analysis in adolescent boys with anorexia nervosa and controls
10.1210/jc.2013-1457 · 2013 · External reference
Resumption of menses in Anorexia Nervosa
10.1001/archpedi.1997.02170380020003 · 1997 · External reference
Impact of low-weight severity and menstrual status on bone in adolescent girls with anorexia nervosa
10.1002/eat.22681 · 2017 · External reference
Bone mineral density, osteoporosis, and fractures among people with eating disorders: a systematic review and meta-analysis
10.1111/acps.12556 · 2016 · External reference
Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis
10.1136/bmj-2023-076410 · 2024 · External reference
Exploring new therapeutic drugs for osteoarthritis and osteoporosis: Glucagon-like peptide-1 receptor agonists: a review
10.1097/md.0000000000043239 · 2025 · External reference
Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes
10.1016/j.lfs.2013.01.001 · 2013 · External reference
Glucagon-like Peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation
10.1210/en.2009-1272 · 2010 · External reference
GLP-1 receptor agonists and the thyroid: C-cell effects in mice are mediated via the GLP-1 receptor and not associated with RET activation
10.1210/en.2011-1864 · 2012 · External reference
Effects of semaglutide and tirzepatide on bone metabolism in type 2 diabetic mice
10.3390/ph17121655 · 2024 · External reference
Vertical sleeve gastrectomy and semaglutide have distinct effects on skeletal health and heart function in obese male mice
10.1152/ajpendo.00521.2024 · 2025 · External reference
Effect of two-year caloric restriction on bone metabolism and bone mineral density in Non-Obese younger adults: a randomized clinical trial
10.1002/jbmr.2701 · 2016 · External reference
20% caloric restriction did not impact bone health nor exercise-induced elevations in bone mass in young female rats
10.1007/s00223-025-01469-4 · 2026 · External reference
The influence of different degrees of energy restriction on bone parameters in young female rats
10.1007/s00223-025-01404-7 · 2025 · External reference
Caloric restriction exerts site-, sex-, and duration-dependent effects on skeletal structure and bone marrow adiposity
10.1530/joe-25-0391 · 2026 · External reference
Diet quality and nutritional adequacy during a 2-year calorie restriction intervention: the Comprehensive Assessment of Long-Term Effects of Reducing Intake of Energy 2 trial
10.1016/j.ajcnut.2025.101182 · 2026 · External reference
Short‐term caloric restriction induced bone loss in both axial and appendicular bones by increasing adiponectin
10.1111/nyas.14380 · 2020 · External reference
Adipsin promotes bone marrow adiposity by priming mesenchymal stem cells
10.7554/elife.69209 · 2021 · External reference
Time-restricted eating for 12 weeks does not adversely alter bone turnover in overweight adults
10.3390/nu13041155 · 2021 · External reference
Time-restricted eating differentially affects bone health and visceral adipose tissue in older women during caloric restriction
10.1016/j.cdnut.2025.106574 · 2025 · External reference
Bone microstructure and metabolism changes under the combined intervention of ketogenic diet with intermittent fasting: an in vivo study of rats
10.1538/expanim.18-0084 · 2019 · External reference
Parathyroid hormone receptor agonists in the management of osteoporosis
10.1038/s41584-025-01287-w · 2025 · External reference
Parathyroid hormone pulsatility: physiological and clinical aspects
10.1038/boneres.2014.49 · 2015 · External reference
Primary hyperparathyroidism
10.5603/ep.a2020.0028 · 2020 · External reference
Primary hyperparathyroidism is associated with abnormal cortical and trabecular microstructure and reduced bone stiffness in postmenopausal women
10.1002/jbmr.1841 · 2013 · External reference
Osteoporosis treatment: recent developments and ongoing challenges
10.1016/s2213-8587(17)30188-2 · 2017 · External reference
Molecular-based treatment strategies for osteoporosis: a literature review
10.3390/ijms20102557 · 2019 · External reference
PTH and the regulation of mesenchymal cells within the bone marrow niche
10.3390/cells13050406 · 2024 · External reference
The role of IL-17 and TH17 cells in the bone catabolic activity of PTH
10.3389/fimmu.2016.00057 · 2016 · External reference
SIKs control osteocyte responses to parathyroid hormone
10.1038/ncomms13176 · 2016 · External reference
Remodeling- and modeling-based bone formation with teriparatide versus denosumab: a longitudinal analysis from baseline to 3 months in the AVA study
10.1002/jbmr.3309 · 2018 · External reference
Lipoprotein receptor–related protein 6 is required for parathyroid hormone–induced Sost suppression
10.1111/nyas.12750 · 2016 · External reference
Effects of histone deacetylase inhibitor scriptaid and parathyroid hormone on osteocyte functions and metabolism
10.1074/jbc.ra118.007312 · 2019 · External reference
Weight loss induced bone loss: mechanism of action and clinical implications
10.1038/s41413-025-00483-4 · 2025 · External reference
Progenitor recruitment and adipogenic lipolysis contribute to the anabolic actions of parathyroid hormone on the skeleton
10.1096/fj.201800948rr · 2019 · External reference
Lactate enhanced the effect of parathyroid hormone on osteoblast differentiation via GPR81-PKC-Akt signaling
10.1016/j.bbrc.2018.06.069 · 2018 · External reference
PTH promotes bone anabolism by stimulating aerobic glycolysis via IGF signaling
10.1002/jbmr.2556 · 2015 · External reference
Conditional loss of Nmp4 in mesenchymal stem progenitor cells enhances PTH-induced bone formation
10.1002/jbmr.4732 · 2020 · External reference
The role of Zfp467 in mediating the pro-osteogenic and anti-adipogenic effects on bone and bone marrow niche
10.1016/j.bone.2020.115832 · 2021 · External reference
PTH regulates osteogenesis and suppresses adipogenesis through Zfp467 in a feed-forward, PTH1R-cyclic AMP-dependent manner
10.7554/elife.83345 · 2023 · External reference
T cell–expressed CD40L potentiates the bone anabolic activity of intermittent PTH treatment
10.1002/jbmr.2394 · 2015 · External reference
Exercise for osteoporosis: a literature review of pathology and mechanism
2022 · External reference
Effects of weight-bearing and weight-supporting sports on bone mass in males
10.2478/pjst-2022-0015 · 2022 · External reference
The effect of intentional weight loss on fracture risk in persons with diabetes: results from the look AHEAD randomized clinical trial
10.1002/jbmr.3214 · 2017 · External reference
Effect of protein supplementation on hip bone mineral density, cortical thickness, and bone strength in older adult participants during a caloric restriction and aerobic exercise weight loss intervention: a randomized controlled trial
10.1007/s00198-026-07845-6 · 2026 · External reference
Pharmacological management of osteoporosis in postmenopausal women: an endocrine society guideline update
10.1210/clinem/dgaa048 · 2020 · External reference
Bone as an endocrine regulator of lipid and energy metabolism
10.1007/s11154-026-10052-7 · 2026 · External reference
Glycerol-driven TNAP activation in thermogenesis and mineralization
10.1038/s41586-026-10396-9 · 2026 · External reference
One year of alendronate after one year of parathyroid hormone (1–84) for osteoporosis
10.1056/nejmoa050336 · 2005 · External reference
The effect of zoledronic acid on bone microarchitecture and strength after Denosumab and Teriparatide Administration: DATA-HD study extension
10.1002/jbmr.4737 · 2020 · External reference
Romosozumab treatment in postmenopausal women with osteoporosis
10.1056/nejmoa1607948 · 2016 · External reference
Bone-forming and antiresorptive effects of romosozumab in postmenopausal women with osteoporosis: bone histomorphometry and microcomputed tomography analysis after 2 and 12 months of treatment
10.1002/jbmr.3735 · 2019 · External reference
One year of romosozumab followed by two years of denosumab maintains fracture risk reductions: results of the FRAME extension study
10.1002/jbmr.3622 · 2019 · External reference
Pre-treatment bone mineral density and the benefit of pharmacologic treatment on fracture risk and BMD change: analysis from the FNIH-ASBMR SABRE project
10.1093/jbmr/zjae068 · 2024 · External reference
Treatment-related changes in total hip bone mineral density are applicable to trials of varied study designs and to drugs with differing mechanisms of action: meta-regression results from the FNIH-ASBMR SABRE study
10.1093/jbmr/zjaf100 · 2025 · External reference
